Developer docs
API playgroundTry for free, no card

Search company profiles

Rubicon Founders

Full company profile

uuid000071w

Namestring
Rubicon Founders
Legal namestring
Rubicon Founders LLC
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Rubicon Founders is a Nashville-based, healthcare-focused private investment firm founded in 2021 by Adam Boehler that builds and grows companies across the healthcare value chain rather than acting as a passive capital provider. Its 14+ portfolio companies span value-based care enablement (Evergreen Nephrology, Honest Health, Imagine Pediatrics, Atlas Oncology Partners), physician practice management (Pediatric Associates, US Heart & Vascular, Privia Health), care delivery (HarmonyCares, Cadre Hospice, Horizon Infusions, Como Care), insurance technology (Indigo), and clinical research services (Caidya, Profound Research). The firm's stated operating model emphasizes active incubation ("build vs. just invest"), in which it originates companies such as Atlas Oncology Partners, Cadre Hospice, and Indigo, leads or co-invests in capital rounds, and provides ongoing operational partnership across the portfolio.

Revenue mechanics are typical of a private investment firm: management fees on committed/invested capital, plus future carried interest realization through exits, IPOs, or secondary transactions on equity ownership in portfolio companies. Rubicon does not publicly disclose fund size, AUM, management fee rates, or LP composition. Portfolio companies, however, have reached material scale: Honest Health reports $1.6B in revenue within three years of operation; Imagine Pediatrics serves approximately 40,000 children with special healthcare needs and reported over $65M in health plan savings in 2024; Indigo insures nearly 1,000 providers and surpassed $10M in premium; HarmonyCares operates across 14 states; and Caidya is a global multi-therapeutic CRO. The firm also operates a centralized job board with 364+ open positions across 13 portfolio companies and produces proprietary content through the "At The Crossing" podcast and "Tech at the Crossing" research series.

The technology layer across the portfolio is built around AI/ML deployment: Indigo's proprietary "Lux" platform automates medical malpractice underwriting (handling ~20% of submissions end-to-end); Imagine Pediatrics integrates EMR, HIE, and claims data for patient cohort segmentation; Delorean AI provides risk stratification models trained on 40 million UnitedHealthcare claims with claimed 80-90% predictive accuracy; and ambient scribing tools (Ambience Healthcare, Suki, eClinicalWorks Sunoh) are deployed across portfolio clinical operations. Adam Boehler, the founder and CEO, is the former director of the CMS Innovation Center, providing regulatory and policy access that is central to the firm's thesis in value-based care.

Short descriptiontext

Rubicon Founders is a Nashville-based, healthcare-focused private investment firm founded in 2021 that builds and grows transformational healthcare companies across value-based care, physician enablement, insurance technology, and clinical research, managing 14+ portfolio companies through active incubation and operational partnership.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare investment, company building, value-based care, physician enablement, portfolio management
Industry1 code
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Investment Returns and Management Fees
TypeLicensing Royalties
Description

Rubicon Founders generates returns through equity ownership in portfolio companies, realized through exits, IPOs, or secondary transactions. The firm builds companies across healthcare services, technology, and enablement platforms.

rubiconfounders.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Tech at the Crossing
Description

An editorial content series exploring AI adoption across the Rubicon Founders portfolio of healthcare companies.

rubiconfounders.com
+1 more record
Core offering1 text field

Rubicon Founders is an entrepreneurial healthcare investment firm that builds and grows transformational healthcare companies. The firm deploys capital and provides operational partnership across a portfolio of more than 14 healthcare companies spanning value-based care enablement, physician practice management, care delivery, insurance technology, clinical research, and behavioral health.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Indigo insures nearly 1,000 providers and surpassed $10M in premium with AI underwriting 20% of submissions
+2 more records
Product overview1 text field

Rubicon Founders is an entrepreneurial healthcare investment firm that builds and grows transformational companies across the healthcare sector. Rather than offering a single unified product, it operates a diversified portfolio of 14 portfolio companies spanning value-based care enablement (Evergreen Nephrology, Honest Health, Imagine Pediatrics), physician practice management (Pediatric Associates, US Heart & Vascular, Privia Health), care delivery (HarmonyCares, Cadre Hospice, Horizon Infusions), insurance technology (Indigo), clinical research (Caidya, Profound Research), oncology enablement (Atlas Oncology Partners), and behavioral health (Como Care). Several portfolio companies employ AI/ML capabilities — Indigo uses proprietary AI underwriting, Imagine Pediatrics uses real-time risk stratification, and US Heart & Vascular embeds AI tools within its EHR — but these are portfolio company products, not a unified Rubicon platform. The firm also produces thought leadership content through the At The Crossing podcast and Tech at the Crossing research series.

Product and service16 records
1Evergreen Nephrology
CategoryValue-Based Care Enablement
Description

Value-based nephrology physician enablement platform that partners with nephrologists to provide interdisciplinary clinical resources, analytical tools, and financial backing across the full kidney disease care spectrum.

2Cadre Hospice
CategoryCare Delivery
Description

Value-oriented hospice provider launched by Rubicon in 2024 that applies proprietary algorithms to partner patient lists to identify candidates for palliative or hospice intervention, serving as a safety net for end-of-life care identification.

3HarmonyCares
CategoryHome Health Care Delivery
Description

Home health managed care platform (formerly U.S. Medical Management) providing in-home primary care under an integrated physician-driven model, including home health, hospice, palliative care, radiology, and laboratory services across 14 states.

4Honest Health
CategoryValue-Based Care Enablement
Description

Value-based primary care physician enablement platform that collaborates with health systems to enhance senior care, control costs, and drive sustainable value-based payment model outcomes through actionable insights and shared accountability.

5Imagine Pediatrics
CategoryValue-Based Care Enablement
Description

Virtual-first value-based care platform for children with special health care needs, combining 24/7 virtual and in-home medical, behavioral, and social support with real-time data-driven risk stratification and actionable patient cohort segmentation.

6Indigo
CategoryInsurance Technology
Description

AI-enabled medical professional liability insurance platform founded in 2023 that uses a proprietary AI risk scoring engine (Lux) to automate underwriting, offering real-time quoting and competitive pricing for physicians and medical groups.

7Pediatric Associates
CategoryPhysician Practice Management
Description

Pediatric physician practice management platform providing operational and clinical support to pediatric practices.

8Privia Health
CategoryPhysician Practice Management
Description

Physician enablement platform helping independent physicians adopt value-based care frameworks and improve practice efficiency.

9Profound Research
CategoryClinical Research
Description

Embedded clinical trial site network enabling community physicians to offer clinical research as a therapeutic option to their patients.

10US Heart & Vascular
CategoryPhysician Practice Management
Description

Cardiology physician practice management platform using eClinicalWorks (eCW) as its unified EHR, with embedded AI tools including Sunoh.ai ambient scribe and healow Genie AI-powered patient engagement.

11Caidya
CategoryClinical Research Organization
Description

Multi-therapeutic clinical research organization (CRO) serving pharmaceutical and biotech innovators with clinical development services from pre-IND strategy through submission and post-marketing surveillance.

12Como Care
CategoryBehavioral Health
Description

Behavioral health platform providing mental health and behavioral health services.

13Horizon Infusions
CategoryCare Delivery
Description

Ambulatory infusion services platform providing independently owned infusion centers for patients receiving intravenous and subcutaneous therapies.

14Atlas Oncology Partners
CategoryValue-Based Care Enablement
Description

Value-based oncology enablement platform that embeds interdisciplinary care teams within community oncology practices to provide navigation, psychosocial support, symptom management, and whole-person longitudinal cancer care, assuming full medical cost risk from payers.

15At The Crossing Podcast
CategoryContent/Media
Description

Rubicon Founders' podcast series exploring how healthcare really works, featuring thought leaders and entrepreneurs discussing healthcare policy, value-based care, AI in healthcare, and clinical innovation.

16Tech at the Crossing
CategoryContent/Research
Description

Multi-episode research series examining AI adoption across the Rubicon portfolio, covering AI and the health services P&L, ambient scribing, and risk stratification, with interviews from portfolio company leaders and AI technology vendors.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

Coalition for Health AI is a collaborative initiative promoting responsible AI development in healthcare. Penguin AI participates in CHAI workgroups and offers 'nutrition facts' labels for AI model transparency.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Rubicon Founders made a $165 million strategic growth investment in Caidya, a global clinical research organization (CRO). Rubicon's partner joined Caidya's board of directors. The funding supports organic growth and potential strategic acquisitions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused PE firm and co-investor in Rubicon's Honest Health round. Operates a comparable model of healthcare buyouts and growth investments with deep sector specialization.

TypeDirect peer
Description

Healthcare and fintech-focused venture and growth firm that co-invested in Imagine Pediatrics and Honest Health alongside Rubicon. Comparable stage and vertical focus.

TypeDirect peer
Description

Led Honest Health's $140M round with Rubicon participation. Healthcare-focused growth equity firm with overlapping thesis in value-based care enablement.

TypeDirect peer
Description

Healthcare services and technology investor that joined Indigo's Series B. Comparable thesis on care delivery transformation and underserved populations.

TypeDirect peer
Description

Early-stage healthcare technology VC that led Atlas Oncology Partners' Series A alongside Rubicon. Overlapping thesis on healthcare AI and value-based care enablement.

TypeDirect peer
Description

Strategic CVC arm of Optum/UnitedHealth Group; existing investor in Indigo and Imagine Pediatrics alongside Rubicon. Comparable healthcare technology thesis at growth stage.

TypeDirect peer
Description

Specialized healthcare debt and equity firm co-investing with Rubicon in Honest Health. Comparable healthcare-specialized investment approach.

TypeDirect peer
Description

Growth-stage healthcare and technology investor that participated in Honest Health. Comparable stage and approach to healthcare growth equity.

TypeBroad incumbent
Description

Large diversified PE/VC firm with a dedicated healthcare and life sciences franchise. Broader in scale and scope than Rubicon, but overlapping thesis across value-based care and health services.

TypeBroad incumbent
Description

Major alternative asset manager with a healthcare growth franchise. Competes for similar value-based care and healthcare services assets at larger scale than Rubicon.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment13 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rubicon Founders

Healthcare Private Equityrubiconfounders.com

Rubicon Founders is a Nashville-based, healthcare-focused private investment firm founded in 2021 that builds and grows transformational healthcare companies across value-based care, physician enablement, insurance technology, and clinical research, managing 14+ portfolio companies through active incubation and operational partnership.

What Rubicon Founders does

Rubicon Founders is a Nashville-based, healthcare-focused private investment firm founded in 2021 by Adam Boehler that builds and grows companies across the healthcare value chain rather than acting as a passive capital provider. Its 14+ portfolio companies span value-based care enablement (Evergreen Nephrology, Honest Health, Imagine Pediatrics, Atlas Oncology Partners), physician practice management (Pediatric Associates, US Heart & Vascular, Privia Health), care delivery (HarmonyCares, Cadre Hospice, Horizon Infusions, Como Care), insurance technology (Indigo), and clinical research services (Caidya, Profound Research). The firm's stated operating model emphasizes active incubation ("build vs. just invest"), in which it originates companies such as Atlas Oncology Partners, Cadre Hospice, and Indigo, leads or co-invests in capital rounds, and provides ongoing operational partnership across the portfolio.

Revenue mechanics are typical of a private investment firm: management fees on committed/invested capital, plus future carried interest realization through exits, IPOs, or secondary transactions on equity ownership in portfolio companies. Rubicon does not publicly disclose fund size, AUM, management fee rates, or LP composition. Portfolio companies, however, have reached material scale: Honest Health reports $1.6B in revenue within three years of operation; Imagine Pediatrics serves approximately 40,000 children with special healthcare needs and reported over $65M in health plan savings in 2024; Indigo insures nearly 1,000 providers and surpassed $10M in premium; HarmonyCares operates across 14 states; and Caidya is a global multi-therapeutic CRO. The firm also operates a centralized job board with 364+ open positions across 13 portfolio companies and produces proprietary content through the "At The Crossing" podcast and "Tech at the Crossing" research series.

The technology layer across the portfolio is built around AI/ML deployment: Indigo's proprietary "Lux" platform automates medical malpractice underwriting (handling ~20% of submissions end-to-end); Imagine Pediatrics integrates EMR, HIE, and claims data for patient cohort segmentation; Delorean AI provides risk stratification models trained on 40 million UnitedHealthcare claims with claimed 80-90% predictive accuracy; and ambient scribing tools (Ambience Healthcare, Suki, eClinicalWorks Sunoh) are deployed across portfolio clinical operations. Adam Boehler, the founder and CEO, is the former director of the CMS Innovation Center, providing regulatory and policy access that is central to the firm's thesis in value-based care.

Rubicon Founders firmographics

Firmographics
Name
Rubicon Founders
Legal name
Rubicon Founders LLC
Website
https://rubiconfounders.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
Rubicon Founders is a Nashville-based, healthcare-focused private investment firm founded in 2021 that builds and grows transformational healthcare companies across value-based care, physician enablement, insurance technology, and clinical research, managing 14+ portfolio companies through active incubation and operational partnership.
Ownership category
akta.pro rank

Rubicon Founders industry classification

Industry
Product category
Healthcare Private Equity
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAB
Healthcare & Life Sciences Growth Equity

Keywords

  • Healthcare investment
  • Company building
  • Value-based care
  • Physician enablement
  • Portfolio management

Where Rubicon Founders is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Rubicon Founders business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Investment Returns and Management Fees: Rubicon Founders generates returns through equity ownership in portfolio companies, realized through exits, IPOs, or secondary transactions. The firm builds companies across healthcare services, technology, and enablement platforms.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Rubicon Founders product offering

Product offering

Core offering

Rubicon Founders is an entrepreneurial healthcare investment firm that builds and grows transformational healthcare companies. The firm deploys capital and provides operational partnership across a portfolio of more than 14 healthcare companies spanning value-based care enablement, physician practice management, care delivery, insurance technology, clinical research, and behavioral health.

Product overview

Rubicon Founders is an entrepreneurial healthcare investment firm that builds and grows transformational companies across the healthcare sector. Rather than offering a single unified product, it operates a diversified portfolio of 14 portfolio companies spanning value-based care enablement (Evergreen Nephrology, Honest Health, Imagine Pediatrics), physician practice management (Pediatric Associates, US Heart & Vascular, Privia Health), care delivery (HarmonyCares, Cadre Hospice, Horizon Infusions), insurance technology (Indigo), clinical research (Caidya, Profound Research), oncology enablement (Atlas Oncology Partners), and behavioral health (Como Care). Several portfolio companies employ AI/ML capabilities — Indigo uses proprietary AI underwriting, Imagine Pediatrics uses real-time risk stratification, and US Heart & Vascular embeds AI tools within its EHR — but these are portfolio company products, not a unified Rubicon platform. The firm also produces thought leadership content through the At The Crossing podcast and Tech at the Crossing research series.

Differentiator

Problem solved

Functional benefit

Brands

  • Tech at the Crossing: An editorial content series exploring AI adoption across the Rubicon Founders portfolio of healthcare companies.
  • At The Crossing Podcast

Products and services

  • Evergreen Nephrology Value-based nephrology physician enablement platform that partners with nephrologists to provide interdisciplinary clinical resources, analytical tools, and financial backing across the full kidney disease care spectrum.
  • Cadre Hospice Value-oriented hospice provider launched by Rubicon in 2024 that applies proprietary algorithms to partner patient lists to identify candidates for palliative or hospice intervention, serving as a safety net for end-of-life care identification.
  • HarmonyCares Home health managed care platform (formerly U.S. Medical Management) providing in-home primary care under an integrated physician-driven model, including home health, hospice, palliative care, radiology, and laboratory services across 14 states.
  • Honest Health Value-based primary care physician enablement platform that collaborates with health systems to enhance senior care, control costs, and drive sustainable value-based payment model outcomes through actionable insights and shared accountability.
  • Imagine Pediatrics Virtual-first value-based care platform for children with special health care needs, combining 24/7 virtual and in-home medical, behavioral, and social support with real-time data-driven risk stratification and actionable patient cohort segmentation.
  • Indigo AI-enabled medical professional liability insurance platform founded in 2023 that uses a proprietary AI risk scoring engine (Lux) to automate underwriting, offering real-time quoting and competitive pricing for physicians and medical groups.
  • Pediatric Associates Pediatric physician practice management platform providing operational and clinical support to pediatric practices.
  • Privia Health Physician enablement platform helping independent physicians adopt value-based care frameworks and improve practice efficiency.
  • Profound Research Embedded clinical trial site network enabling community physicians to offer clinical research as a therapeutic option to their patients.
  • US Heart & Vascular Cardiology physician practice management platform using eClinicalWorks (eCW) as its unified EHR, with embedded AI tools including Sunoh.ai ambient scribe and healow Genie AI-powered patient engagement.
  • Caidya Multi-therapeutic clinical research organization (CRO) serving pharmaceutical and biotech innovators with clinical development services from pre-IND strategy through submission and post-marketing surveillance.
  • Como Care Behavioral health platform providing mental health and behavioral health services.
  • Horizon Infusions Ambulatory infusion services platform providing independently owned infusion centers for patients receiving intravenous and subcutaneous therapies.
  • Atlas Oncology Partners Value-based oncology enablement platform that embeds interdisciplinary care teams within community oncology practices to provide navigation, psychosocial support, symptom management, and whole-person longitudinal cancer care, assuming full medical cost risk from payers.
  • At The Crossing Podcast Rubicon Founders' podcast series exploring how healthcare really works, featuring thought leaders and entrepreneurs discussing healthcare policy, value-based care, AI in healthcare, and clinical innovation.
  • Tech at the Crossing Multi-episode research series examining AI adoption across the Rubicon portfolio, covering AI and the health services P&L, ambient scribing, and risk stratification, with interviews from portfolio company leaders and AI technology vendors.

Quantifiable outcome

  • Indigo insures nearly 1,000 providers and surpassed $10M in premium with AI underwriting 20% of submissions
  • +2 more outcomes

Companies that use Rubicon Founders

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Rubicon Founders technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature3 records

Rubicon Founders partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • Coalition for Health AI (CHAI)minorStrategic or Co-development Partner · 1 March 2025Coalition for Health AI is a collaborative initiative promoting responsible AI development in healthcare. Penguin AI participates in CHAI workgroups and offers 'nutrition facts' labels for AI model transparency.
  • CaidyacoreStrategic or Co-development Partner · 1 January 2025Rubicon Founders made a $165 million strategic growth investment in Caidya, a global clinical research organization (CRO). Rubicon's partner joined Caidya's board of directors. The funding supports organic growth and potential strategic acquisitions.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Rubicon Founders competitors and assessment

Company assessment

Direct peers

  • Welsh, Carson, Anderson & Stowe (WCAS): Healthcare-focused PE firm and co-investor in Rubicon's Honest Health round. Operates a comparable model of healthcare buyouts and growth investments with deep sector specialization.
  • Oak HC/FT: Healthcare and fintech-focused venture and growth firm that co-invested in Imagine Pediatrics and Honest Health alongside Rubicon. Comparable stage and vertical focus.
  • NewSpring Healthcare: Led Honest Health's $140M round with Rubicon participation. Healthcare-focused growth equity firm with overlapping thesis in value-based care enablement.
  • Town Hall Ventures: Healthcare services and technology investor that joined Indigo's Series B. Comparable thesis on care delivery transformation and underserved populations.
  • Flare Capital Partners: Early-stage healthcare technology VC that led Atlas Oncology Partners' Series A alongside Rubicon. Overlapping thesis on healthcare AI and value-based care enablement.
  • Optum Ventures: Strategic CVC arm of Optum/UnitedHealth Group; existing investor in Indigo and Imagine Pediatrics alongside Rubicon. Comparable healthcare technology thesis at growth stage.
  • K2 HealthVentures: Specialized healthcare debt and equity firm co-investing with Rubicon in Honest Health. Comparable healthcare-specialized investment approach.
  • Durable Capital Partners: Growth-stage healthcare and technology investor that participated in Honest Health. Comparable stage and approach to healthcare growth equity.

Broad incumbents

  • Bain Capital Life Sciences: Large diversified PE/VC firm with a dedicated healthcare and life sciences franchise. Broader in scale and scope than Rubicon, but overlapping thesis across value-based care and health services.
  • KKR Health Care Strategic Growth: Major alternative asset manager with a healthcare growth franchise. Competes for similar value-based care and healthcare services assets at larger scale than Rubicon.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Rubicon Founders social profiles

Digital presence

Rubicon Founders financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rubicon Founders leadership team

Management profile

Number of profiles

Profiles2 records

Rubicon Founders funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rubicon Founders M&A and investment

M&A and investment

M&A2 records

Investments13 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rubicon Founders

What does Rubicon Founders do?

Rubicon Founders is an entrepreneurial healthcare investment firm that builds and grows transformational healthcare companies. The firm deploys capital and provides operational partnership across a portfolio of more than 14 healthcare companies spanning value-based care enablement, physician practice management, care delivery, insurance technology, clinical research, and behavioral health.

Is Rubicon Founders a public or private company?

Rubicon Founders is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Rubicon Founders founded?

Rubicon Founders was founded in 2021. It employs 51 to 100 people.

Where is Rubicon Founders based?

Rubicon Founders is headquartered in Nashville, United States, in the North America region.

How does Rubicon Founders make money?

One revenue line is on record: investment Returns and Management Fees.

Who are Rubicon Founders's main competitors?

Direct peers on record are Welsh, Carson, Anderson & Stowe (WCAS), Oak HC/FT, NewSpring Healthcare, Town Hall Ventures, Flare Capital Partners, Optum Ventures, K2 HealthVentures and Durable Capital Partners. Broad incumbents are Bain Capital Life Sciences and KKR Health Care Strategic Growth.

Does Rubicon Founders have an API?

No public API is recorded for Rubicon Founders.

What industry is Rubicon Founders in?

Rubicon Founders's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Insurance$50 million funding round for med liability platformIndigo, a medical professional liability platform, announced it closed a $50 million oversubscribed Series B funding round led by existing investor Rubicon Founders, with participation from new investor Town Hall Ventures and existing investors including Optum Ventures. The capital will fund continued expansion of Indigo's AI-powered underwriting and distribution platform that customizes coverage for physicians across specialties. Founded in 2023, the company insures nearly 1,000 providers nationwide, with AI underwriting 20% of submissions by the end of 2025.PR NewswireImagine Pediatrics Raises $67M to Expand Access to Value-Based Care for Children with Special Health Care NeedsImagine Pediatrics raised $67M in Series B funding to expand access to value-based care for children with special health care needs. The company, founded in 2022, now serves about 40,000 children and has completed nearly 300,000 patient encounters, saving partners over $65 million in 2024.Business Wire BlogRubicon Founders Announces Investment in Horizon Infusions to Support ExpansionRubicon Founders made a majority investment in Horizon Infusions, Ohio's largest network of ambulatory infusion centers, with BroadOak Capital remaining a minority investor. Horizon operates 21 centers statewide, and Rubicon aims to support its expansion within Ohio and new markets.FinSMEsCaidya Receives $165M Growth Investment From Rubicon FoundersCaidya, a Raleigh-based clinical research organization, received a $165M growth investment from Rubicon Founders. The company will use the funds to support organic expansion and explore strategic acquisitions. Caidya operates in 23 countries and focuses on oncology, hematology, and rare diseases.HIT ConsultantRubicon Founders Invests $165M in Caidya to Fuel Global ExpansionRubicon Founders invested $165 million in Caidya, a global clinical research organization, to support its expansion and strategic acquisitions. The investment will fund organic growth and potential acquisitions, with David M. Glaccum joining Caidya's board. Caidya operates in 23 countries and aims to accelerate drug development for unmet medical needs.YahooCaidya Announces $165 Million Strategic Growth Investment From Rubicon FoundersCaidya closed a $165 million strategic growth investment from Rubicon Founders, a U.S. healthcare investment firm. The funds will support organic expansion and strategic acquisitions, with David M. Glaccum joining Caidya's board. Caidya operates in 23 countries and regions.Business Wire BlogCaidya Announces $165 Million Strategic Growth Investment From Rubicon FoundersCaidya closed a $165 million strategic growth investment from Rubicon Founders, a U.S. healthcare investment firm. The funds will support organic expansion and strategic acquisitions, with David M. Glaccum joining Caidya's board. Caidya operates in 23 countries and regions.CNBCTrump picks Adam Boehler to be presidential envoy for hostage affairsPresident-elect Donald Trump announced he has selected Adam Boehler, CEO of healthcare investment firm Rubicon Founders, to serve as special presidential envoy for hostage affairs with the personal rank of ambassador. The appointment follows news that American citizen Omer Neutra, a hostage in Gaza believed to be alive, was killed during the October 7, 2023 Hamas attacks, with approximately 100 hostages still held. Boehler, who previously served as CEO of the U.S. International Development Finance Corporation and was a negotiator on the 2020 Abraham Accords, will replace current special envoy Roger Carstens.NBC 7 San DiegoTrump picks former Development Finance Corp. CEO Adam Boehler as special envoy for hostage affairsTrump appointed Adam Boehler, CEO of Rubicon Founders, as special presidential envoy for hostage affairs. Boehler previously negotiated the Abraham Accords in 2020. The appointment follows news that hostage Omer Neutra was killed in the Oct. 7 Hamas attack, with about 100 hostages still held.PR NewswireCano Health Announces Closing of $150 Million Term Loan Facility with Diameter Capital Partners and Rubicon FoundersCano Health closed a $150 million senior secured term loan on February 24, 2023, with lenders Diameter Capital Partners and Rubicon Founders. The loan bears 14% interest for two years, then 13%, and Cano Health will use proceeds for general corporate purposes, including repaying its revolving credit facility.